NET PROFIT (x1000 EUR)
EMPLOYEES
Acadia Pharmaceuticals A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-20
|
-34
|
-3 |
| Total assets |
0
|
1
|
1 |
| Current assets |
0
|
1
|
1 |
| Current liabilities |
134
|
114
|
80 |
| Equity capital |
-133
|
-113
|
-79 |
| - share capital |
81
|
81
|
81 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-11300%
|
-7900% | |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
0%
|
0.9%
|
1.2% |
| Return on equity (ROE) |
15.0%
|
30.1%
|
3.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.